|
GAB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.54779999992105E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47920034396532E-10 |
| Normal-vs-Stage2 |
1.373650E-02 |
| Normal-vs-Stage3 |
1.128390E-01 |
| Normal-vs-Stage4 |
2.426200E-01 |
| Stage1-vs-Stage2 |
2.548600E-01 |
| Stage1-vs-Stage3 |
2.34199999999962E-05 |
| Stage1-vs-Stage4 |
2.42520000000024E-05 |
| Stage2-vs-Stage3 |
1.385400E-01 |
| Stage2-vs-Stage4 |
1.024630E-01 |
| Stage3-vs-Stage4 |
7.758400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25690000021928E-07 |
| Normal-vs-AfricanAmerican |
8.550200E-02 |
| Normal-vs-Asian |
4.872000E-01 |
| Caucasian-vs-AfricanAmerican |
2.382400E-01 |
| Caucasian-vs-Asian |
6.863800E-01 |
| AfricanAmerican-vs-Asian |
9.512400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12990000000757E-06 |
| Normal-vs-Female |
1.438810E-04 |
| Male-vs-Female |
5.805200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.038300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.51650000002057E-07 |
| Normal-vs-Age(61-80Yrs) |
6.359100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.695800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.827200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.699200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.329000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.606000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.802100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.843200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.38299999999469E-06 |
| Normal-vs-Grade 2 |
7.52059999831189E-08 |
| Normal-vs-Grade 3 |
3.443700E-04 |
| Normal-vs-Grade 4 |
3.846800E-01 |
| Grade 1-vs-Grade 2 |
1.909170E-01 |
| Grade 1-vs-Grade 3 |
1.234000E-01 |
| Grade 1-vs-Grade 4 |
2.702100E-03 |
| Grade 2-vs-Grade 3 |
2.139200E-01 |
| Grade 2-vs-Grade 4 |
1.678230E-03 |
| Grade 3-vs-Grade 4 |
3.152200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.52459974936903E-10 |
| Normal-vs-ccB subtype |
1.184860E-03 |
| ccA subtype-vs-ccB subtype |
3.177500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94766999999096E-05 |
| Normal-vs-N1 |
5.231400E-01 |
| N0-vs-N1 |
3.468200E-01 |
|
|
